Filter
951
Filtered Results: 951
Text search:
gambia
Featured
Recommendations
61
New Publications
246
Language
Document type
No document type
556
Studies & Reports
237
Guidelines
51
Manuals
35
Strategic & Response Plan
28
Fact sheets
16
Training Material
6
Situation Updates
6
Resource Platforms
5
Infographics
5
Brochures
4
Dashboards/Maps
2
Countries / Regions
Indonesia
114
Africa
61
Global
57
Senegal
54
Sierra Leone
39
Guinea
35
Liberia
31
West and Central Africa
20
Germany
18
Congo, Democratic Republic of
17
Uganda
17
Burkina Faso
16
Ethiopia
15
Kenya
13
Ghana
13
Mozambique
12
Cameroon
11
Mali
11
Nigeria
10
Gambia
9
Rwanda
9
East and Southern Africa
9
Chad
9
Tanzania
8
South Africa
8
Togo
7
Zambia
7
Malawi
6
Guinea-Bissau
6
Latin America and the Carribbean
6
Western and Central Europe
6
Côte d’Ivoire / Ivory Coast
6
Bangladesh
6
Zimbabwe
5
Middle East and North Africa
5
Central African Republic
5
South Sudan
5
Myanmar / Burma
5
Nepal
4
Lesotho
4
Benin
4
Niger
4
Namibia
4
Somalia
4
Haiti
3
Cambodia
3
Jordan
3
Brazil
3
Russia
3
Sudan
3
Angola
3
Botswana
3
India
3
Syria
2
Mauritania
2
South–East Asia Region
2
Lebanon
2
Yemen
2
Madagascar
2
Eswatini/ Swaziland
2
Colombia
1
Thailand
1
Ukraine
1
Kazakhstan
1
Afghanistan
1
Peru
1
Philippines
1
Venezuela
1
Eastern Europe and Central Asia
1
North America
1
Maldives
1
Mauritius
1
Southern Africa
1
Argentina
1
Vietnam
1
Eastern Europe
1
Papua New Guinea
1
Djibouti
1
Egypt
1
Greece
1
Libya
1
Iraq
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
350
Women & Child Health
82
Clinical Guidelines
81
Public Health
73
Key Resources
33
Capacity Building
15
Pharmacy & Technologies
9
Toolboxes
NTDs
87
Ebola & Marburg
50
Refugee
44
Mental Health
42
HIV
38
Planetary Health
38
COVID-19
36
Rapid Response
34
TB
31
Disability
26
Global Health Education
25
AMR
16
Health Financing Toolbox
14
Caregiver
11
Pharmacy
10
Conflict
8
Zika
7
Natural Hazards
6
NCDs
6
Polio
4
Specific Hazards
3
Cholera
2
Malaria
1
The document summarizes the infrastructure and activities for Ebola virus disease (EVD) preparedness that are already in place in the Gambia and identifies opportunities for improvement to strengthen the nation’s readiness in the event of an EVD incident.
In February 2014, there was an outbreak of the Ebola Virus Disease (EVD) in Guinea, which has spread to Liberia, Mali, Nigeria, Senegal and Sierra Leone causing untold hardship and hundreds of deaths in these countries. As of 6 March 2015, a total of 24,282 cases, and 9,976 deaths, which were attrib...
According to the previous NHSSP 2014 - 2020, the long-term health sector objective is “the provision of adequate, effective and affordable health care for all Gambians.” The overall ob-jective for the previous plan 2014-20 was “to reduce inequalities in health care services and reverse the dow...
Republic of The Gambia; Accessed on 31.01.2019
Gambiense human African trypanosomiasis is a deadly infectious disease affecting West and Central Africa, South Sudan and Uganda, and transmitted between humans by tsetse flies. The disease has caused several major epidemics, the latest one in the 1990s. Thanks to recent innovations such as rapid di...
Sleeping sickness is controlled by case detection and treatment but this often only reaches less than 75% of the population. Vector control is capable of completely interrupting HAT transmission but is not used because of expense. We conducted a full scale field trial of a refined vector control tec...
DNDi is now striving to make fexinidazole available to the majority of people who have T.b. gambiense sleeping sickness. We are supporting a three-year access and pharmacovigilance study that began in 2020 and have so far carried out in-country training of relevant staff in 250 hospitals and...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
The main purpose of the meeting was to review tsetse control tools, activities and their contribution to the elimination of gHAT and the monitoring thereof. Seven endemic countries provided reports on recent and ongoing vector control interventions at the national level (Angola, Cameroon, Côte d’...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form...
HAT diagnosis relies on laboratory techniques because clinical signs and symptoms are unspecific. Serodiagnostic tests exist only for Tbg and are based on the detection of specific antibodies, thus they are not confirmatory of infection. With the current low disease prevalence, the positive predicti...
HAT diagnosis relies on laboratory techniques because clinical signs and symptoms are unspecific. Serodiagnostic tests exist only for Tbg and are based on the detection of specific antibodies, thus they are not confirmatory of infection. With the current low disease prevalence, the positive predicti...
WHO convened the fifth stakeholders meeting on the elimination of HAT due to infection with Trypanosoma brucei gambiense (g-HAT) and Trypanosoma brucei rhodesiense (r-HAT) in Geneva, Switzerland, on 7–9 June 2023. The meeting was held again in person after the coronavirus disease (COVID-19) pandem...
Having established the goal of eliminating transmission of gambiense human African trypanosomiasis (g-HAT) to humans, the HAT-e-TAG considered which elements should be developed to assess this goal.
The Global Health Observatory
Les progrès remarquables réalisés dans la lutte contre la forme à T. b. gambiense reposent sur le dépistage et le traitement curatif, une stratégie qui interrompt la transmission en réduisant le réservoir de parasites chez l’être humain. Parfois, cette
approche a été combinée avec des...
Database with maps and country-specific numbers
Human African trypanosomiasis is caused by Trypanosoma brucei gambiense in West and Central Africa and by T. brucei rhodesiense in East Africa; both species are endemic in Uganda. Trypanosoma brucei gambiense accounts for 98% of all cases of African trypanosomiasis, and T. brucei rhodesiense account...
More countries eliminate human African trypanosomiasis as a public health problem: Benin and Uganda (gambiense form) and Rwanda (rhodesiense form)
Human African trypanosomiasis (HAT), or sleeping sickness, transmitted by tsetse flies in sub-Saharan Africa, is a life-threatening disease that afflict...
